Cogent Biosciences (COGT) Misses Q4 Earnings Expectations

Cogent Biosciences (NASDAQ:COGT) reported quarterly earnings results on February 17, 2026 that fell short of analyst expectations.

The Healthcare company reported earnings per share of $-0.61, missing the consensus estimate of $-0.51 by $0.10 per share. Revenue came in at , meeting the estimate of .

Cogent Biosciences's stock moved following the earnings release. The stock currently trades at $37.80 with a market capitalization of $5.7B.